Panacea BioMatx, Inc. — Form D
Panacea BioMatx, Inc. of RESEARCH TRIANGLE PARK, NC, a company, filed a Form D exempt-offering notice with the SEC on 2014-04-16. The offering totals $500K, of which $267K was reported sold. Industry: Other Health Care.
Offering
- Filed: 2014-04-16
- Form: D
- Accession: 0001605753-14-000001
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $500K
- Amount sold: $267K
- Remaining: $233K
- Minimum investment: $2K
- Investors: 16
- Date of first sale: 2014-04-01
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-215722
Issuer
- Name: Panacea BioMatx, Inc.
- CIK: 0001605753
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2013
- Address: 2 DAVIS DRIVE, RESEARCH TRIANGLE PARK, NC, 27709
- Phone: 919 215 9358
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Edison Thurman Hudson | Director | Chapel Hill, NC |
| Lloyd Staton Noel | Director | Durham, NC |
| Thomas H Roberg | Director | Raleigh, NC |
| Jeffrey Joseph Eshelman Bourn | Executive Officer | Pittsboro, NC |
| Edison Thurman Hudson | Executive Officer | Chapel Hill, NC |
| Lloyd Staton Noel | Executive Officer | Durham, NC |
More